Genomics Market Latest Innovations, Drivers and Industry Key Events 2022– 2030: Grand View Research Inc.

 Genomics Market Growth & Trends

The global genomics market size is expected to reach USD 94.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 16.4% in the forecast period owing to the increasing demand for novel therapeutic and research applications in genomics. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics’ barcode technology to screen single cells using CRISPR libraries.

Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.

Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual’s genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.

The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.

One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.

Request a free sample copy or view report summary: Genomics Market Report

Genomics Market Report Highlights

• The overall growth of the genomics market is attributed to the rising dependence of novel therapeutics for genetic disorders and cancers on genomics-based understanding
• Functional genomics held the largest market share in the year 2021, owing to the demand for rising applications in diagnostics and gene therapy. Biomarker discovery is anticipated to be the fastest-growing segment in the forecast period due to rising applications of biomarkers in disease and therapeutics research
• North America dominated the market in 2021 due to the presence of key players and rising support from the government and research institutes to advance the research on Genomics in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/genomics-market-analysis

Genomics Market Segmentation

Grand View Research has segmented the global genomics market on the basis of application, deliverables, end-use, and region:

Genomics Application & Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Functional Genomics
  • Real-Time PCR
  • Transfection
  • SNP Analysis
  • Mutational Analysis
  • Microarray Analysis
  • RNA Interference
• Epigenomics
  • Bisulfite Sequencing
  • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
  • Methylated DNA Immunoprecipitation (MeDIP)
  • High Resolution Melt (HRM)
  • Chromatin Accessibility Assays
  • Microarray Analysis
• Pathway Analysis
  • Microarray Analysis
  • Bead-Based Analysis
  • Real-time PCR
  • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
• Biomarker Discovery
  • DNA Sequencing
  • Microarray Analysis
  • Real-time PCR
  • Mass Spectrometry
  • Statistical Analysis
  • Bioinformatics
• Others

Genomics Deliverables Outlook (Revenue, USD Million, 2018 - 2030)

• Products
  • Instruments/Systems/Software
  • Consumables & Reagents
• Services
  • Core Genomics services
  • NGS-based Services
  • Biomarker Translational Services
  • Computational Services
  • Others

Genomics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Research
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Genomics Market

• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• BGI Genomics
• Color Genomics, Inc.
• Danaher Corporation
• Eppendorf AG
• Eurofins Scientific
• Hoffmann-La Roche Ltd.
• GE Healthcare
• Illumina, Inc.
• Myriad Genetics, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific, Inc.
• 23andMe, Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Phosphoric Acid Market Set to Record Exponential Growth by 2027: Grand View Research Inc.

 Phosphoric Acid Market Growth & Trends

The global phosphoric acid market size is projected to reach USD 61.0 billion by 2027 registering a CAGR of 3.7%, according to a new report by Grand View Research, Inc. increasing production of fertilizers owing to the development in the global agricultural sector is expected to augment the product demand.

Fertilizers is the key point of application for phosphoric acid wherein the product is used to formulate Diammonium Hydrogen Phosphate (DAP), Mono Ammonium Dihydrogen Phosphate (MAP), and Triple Superphosphate (TAP). Among these, DAP constituted the largest share of the market, in terms of volume, in 2019. The growing need for nutrients internationally on account of increasing world population is anticipated to augment fertilizers industry. As a result, the manufacturers are set to expand their production capacity to cater to the growing demand.

For instance, in June 2019, EuroChem opened its third fertilizer blending plant in Brazil, which has a capacity of 6 kilotons per day. According to the International Fertilizer Industry Association, the global capacity of nitrogen, phosphoric acid, and potash is expected to rise significantly of which phosphoric acid is expected to register highest growth rate. The product is expected to witness an increase of around 2% in its global capacity from 2018 to 2021. Asia Pacific was the major consumer in 2019 and this trend is expected to continue over the forecast period.

The growth can be attributed to rising production of fertilizers in China. The growth, however, is anticipated to be hindered in 2020 on account of the Covid-19 pandemic, which is believed to be originated from China. Hubei was the key producer of MAP and DAP in the country. However, as of February 2020, only four manufacturers are engaged in production, rest all other phosphate plants had suspended their operations, which impacted half of the Hubei’s phosphate industry.

The production and consumption of fertilizers is anticipated to grow by 2021, owing to the increasing productivity in agricultural sector. For instance, in India, which is amongst the key crop producers in the world, the food grain production increased by 6.74 million tons from 2018-19 to 2019-20.

Major companies focus on capacity expansion to gain competitive advantage. For instance, in November 2019, Paradeep Phosphates gave Thyssenkrupp Industrial Solutions contract to expand their phosphoric acid plant in Odisha, India. The project will increase the plant’s capacity from 1,000 tons to 1,400 tons of production per day.

Request a free sample copy or view report summary: Phosphoric Acid Market Report

Phosphoric Acid Market Report Highlights

• DAP accounted for the largest volume share in 2019 on account of its high nutrient grade, which leads to cost reduction in terms of handling, freight, as well as application and is projected to grow at a volumetric CAGR of 2.8% from 2020 to 2027
• Phosphoric acid is majorly produced by two commercial methods, which include wet process and thermal process; wherein more than 50% of the global production sites utilize Prayon Technology (wet process technology)
• Asia Pacific is expected to register the fastest growth rate of 3.5%, in terms of volume, over the forecast period, owing to increasing production of fertilizers in the region
• The market is highly competitive and thus, manufacturers are investing in production capacity expansion
• For example, in December 2019, CSCEC and Wengfu Group collaborated to build a phosphoric acid plant with Phosphate Misr Company in Egypt with a total investment of USD 848 million

Access Press Release@ https://www.grandviewresearch.com/press-release/global-phosphoric-acid-market

Phosphoric Acid Market Segmentation

Grand View Research has segmented the global phosphoric acid market on the basis of application and region

Phosphoric Acid Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016- 2027)

• Diamonium Hydrogenphosphate (DAP)
• Monoammonium Dihydrogenphosphate (MAP)
• Triple Superphosphate (TSP)
• Other Fertilizers
• Other Applications

Phosphoric Acid Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Peru
  • Argentina
  • Chile
• Africa
  • Egypt
  • Morocco
  • South Africa
  • Tunisia
  • Senegal
• Middle East
  • Saudi Arabia
  • Israel
  • Jordan
  • Turkey
• Europe
  • Belgium
  • France
  • Germany
  • Russia
  • Spain
• Asia Pacific
  • China
  • Indonesia
  • Japan
  • India
  • Thailand
  • Vietnam

List of Key Players of Phosphoric Acid Market

• The Mosaic Company
• PJSC PhosAgro
• Nutrien
• IFFCO
• EuroChem Group AG
• Prayon Group
• Israel Chemical Ltd.
• Yara International
• OCP S.A.
• Aditya Birla Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fire Fighting Foam Market Overview, Analysis And Forecast To 2030: Grand View Research Inc.

 Fire Fighting Foam Market Growth & Trends

The global fire fighting foam market size is anticipated to reach USD 6.73 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to propel at a CAGR of 3.6% over the forecast period. Increasing fire-related accidents and wildfires across the globe due to various factors, such as climatic changes, human errors, electrical faults, and gas leakage, are anticipated to drive the industry over the forecast period. The Aqueous Film Forming Foam (AFFF) segment led the global industry in 2021. The Asia Pacific region is expected to be the largest and fastest-growing regional market by 2030 due to increasing fire incidents resulting in loss of life and damage to property and the environment.

For instance, in 2021, Hong Kong witnessed a major fire breakout across a skyscraper building, captivating and injuring numerous people. Hence, rising fire incidents are propelling product demand and are expected to follow a similar trend throughout the forecast period. New product development and acquisitions are the major strategies adopted by companies to capture the industry. For instance, in April 2021, Johnson Controls introduced Chemguard 3×3, a non-fluorinated foam concentrate, which is expected to deliver effective and impulsive fire suppression of Class B hydrocarbon and polar solvent fuel fires.

Request a free sample copy or view the report summary: Fire Fighting Foam Market Report

Fire Fighting Foam Market Report Highlights

• The Aqueous Film Forming Foam (AFFF) segment led the industry in 2021 owing to the property of AFFF of instant form formation upon ejection of the concentrate or water mix from the nozzle
• The class A segment dominated the global industry in 2021. Class A fires involve common combustible substances, such as fabric, wood, paper, and plastics
• These accidental fires are common in various industries since these fires can intensify at a high rate in the presence of fuel abundance
• Growing fire-related accidents due to numerous factors across North America, Europe, and the Asia Pacific are expected to fuel the industry growth
• Furthermore, the foam blanket suppresses the oxygen supply to flammable material, hence preventing combustible evaporation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-fire-fighting-foam-market

Fire Fighting Foam Market Growth & Trends

Grand View Research has segmented the global fire fighting foam market report based on basis of product, application, and region:

Fire Fighting Foam Type Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Aqueous Film Forming Foam (AFFF)
• Alcohol Resistant Aqueous Film Forming Foam (AR-AFFF)
• Protein Foam
• Synthetic Detergent Foam

Fire Fighting Foam Fire Type Outlook (Volume, Kilotons; Revenue, USD Million; 2019 - 2030)

• Class A
• Class B
• Class C

Fire Fighting Foam End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Oil & Gas
• Automotive
• Chemical
• Aviation
• Marine
• Mining
• Others

Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East and Africa
  • GCC Countries
  • South Africa

List of Key Players in the Fire Fighting Foam Market

• BIO EX S.A.S.
• ANGUS FIRE
• National Foam
• Perimeter Solution
• DIC Corporation
• Johnson Controls
• Dafo Fomtec AB
• Fabrik Chemischer Praparate von Dr. Richard Sthamber GmbH & Co. KG
• Kerr Fire
• SFFECO GLOBAL

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Short-term Vacation Rental Market Expected To Trigger A Revenue To USD 256.31 Billion By 2030: Grand View Research, Inc.

 Short-term Vacation Rental Market Growth & Trends

The global short-term vacation rental market size is expected to reach USD 256.31 billion by 2030, registering a CAGR of 11.1% during the forecast period, according to a new report by Grand View Research, Inc. The stay-at-home restrictions during the COVID-19 pandemic have led people to plan out staycations or short-term vacation spot-pandemic. This has created more need for staycation places and is contributing to the growth of the industry. Rising expenditure on travel and tourism, demand for eco-friendly stays, and increasing per capita expenditure will further bolster industry growth. The distinction between work and fun is becoming hazier in the post-pandemic era, and the rise of the work-from-home trend has made work more flexible.

This resulted in travel growth across the globe with travelers experiencing new places putting work-life balance into the form of equilibrium. Offering an attractive proposition, short-term vacation rentals can provide a great return on investment to the landlords helping them achieve larger profits as compared to traditional long-term rentals, by utilizing hosting platforms, such as Booking.com and Airbnb, creating better industry prospects. In terms of accommodation type, the home segment dominated the industry and is expected to account for the largest market share over the forecast period. In general, families or groups of friends traveling together aren’t catered to well by the majority of hotels. Visitors can easily spend the majority of their budget before they even begin due to the cost of dining out and the necessity of reserving multiple rooms to fit everyone.

Fortunately, it’s simple to locate vacation houses that can accommodate any size gathering. Visitors can save a lot of cash by consuming at least a few of their meals at home, in addition to the necessities (plenty of bedrooms, toilets, and televisions). North America held the largest share in 2021owing to a rise in the inclination of people in North America towards hotels & restaurants due to tourism. North America is surrounded by oceans on all sides and is home to many breathtaking locales & landscapes, which makes it one of the most sought-after tourist destinations in the world. Government initiatives are expected to play a major role in the global market by making heavy investments in infrastructure and connectivity development, particularly in developing countries while opening a plethora of opportunities for industry players to expand their portfolios and contribute to the growth.

Request a free sample copy or view report summary: Short-term Vacation Rental Market Report

Short-term Vacation Rental Market Report Highlights

• The home segment led the global industry in 2021 and is projected to expand further at a significant CAGR during the forecast period
• Vacation home rentals offer the finest of both worlds, allowing guests to unwind in the comfort and solitude of their own house while still taking advantage of the luxuries offered by a hotel
• The online/platform-based segment is expected to witness substantial growth during the forecast period. The increasing penetration of internet and smartphone devices across nations is augmenting the growth of online bookings through the rising number of monthly visitors
• North America was the dominant region in 2021. The growth is attributed to the region’s attraction points, such as its pristine lakes, modern cityscapes, historical sites, white sand beaches, and varied climatic conditions
• com, an Expedia Group, Inc. company, in December 2020, was named the official travel partner of the NBA. The agreement will allow Hotel.com to engage with NBA fans and travelers through integrated marketing efforts, which will illustrate that using Hotel.com is the most rewarding way to book accommodations

Access Press Release@ https://www.grandviewresearch.com/press-release/global-short-term-vacation-rental-market

Short-term Vacation Rental Market Segmentation

Grand View Research has segmented the global short-term vacation rental market based on accommodation type, booking mode, and region:

Short-term Vacation Rental Accommodation Type Outlook (USD Million, 2017 - 2030)

• Home
• Apartments
• Resort/Condominium
• Others

Short-term Vacation Rental Booking Mode Outlook (Revenue, USD Million, 2017 - 2030)

• Online
• Offline

Short-term Vacation Rental Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in the Short-term Vacation Rental Market

• com Pte. Ltd.
• Airbnb, Inc.
• Booking Holdings, Inc.
• Expedia Group, Inc.
• Hotelplan Management AG
• MakeMyTrip Pvt. Ltd.
• NOVASOL A/S
• Oravel Stays Pvt. Ltd.
• TripAdvisor, Inc.
• Wyndham Destinations Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dried Blood Spot Collection Cards Market Expected to Collect USD 517.2 Million by the End of 2030: Grand View Research Inc.

 Dried Blood Spot Collection Cards Market Growth & Trends

The global dried blood spot collection cards market size is expected to reach USD 517.2 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.2% from 2022 to 2030. Dried blood spot (DBS) collection cards are used to diagnose infectious diseases, particularly in resource-constrained areas, or to screen newborns for inherited metabolic problems, with a range of novel and innovative DBS uses only lately emerging.

Growing research studies for DBS testing and its advantages for diagnostic purposes are expected to fuel the market growth during the forecast period. In addition, the WHO recently recommended dried blood spot collection cards for diagnosis of HIV and hepatitis B & C due to the benefits of DBS in collecting blood and transport.

Moreover, dried blood spot collection cards have been used in a variety of toxicology applications, including toxicokinetics, epidemiological, environmental, and forensic toxicology. Dried blood spot collection cards are anticipated to be used as a sample preparation approach in forensic toxicology, and they can cost-effectively retain evidence for closed cases. Screening procedures as well as follow-up of markers of clinical or forensic interest are further toxicological applications where these cards may be progressively utilized.

Developing economies in Africa and Asia have the highest prevalence of rabies. The detection and surveillance of such diseases are hampered by the absence of clinical laboratories. Through dried blood spot collection cards, rabies can be diagnosed with limited resources. As per the data published by the Australian Trade and Investment Commission, Australia has become home to a thriving network of more than 470 biotechnology companies. A high number of established biotechnology and pharmaceutical players and extensive R&D initiatives being undertaken by them are expected to create a high need for DBS testing for therapeutic drug monitoring applications.

Various international organizations such as the U.S. Food and Drug Administration and the World Health Organization acknowledge the role of DBS cards in this pandemic. For instance, In June 2021, Symbiotic, Inc. was granted EUA by the FDA for a COVID-19 self-collect antibody test. This test can be conducted using ELISA with DBS for detecting COVID-19 antibodies in individuals aged 18 years and older, with collecting the sample in children aged 5 years and older by an adult.

The increase in the adoption of dried blood spot collection cards for therapeutic drug monitoring is a major factor expected to boost market growth in the near future. For instance, in July 2022, a study was conducted by researchers from the University of Washington and Med Biotech Laboratories to assess the feasibility of at-home dried blood spot collection along with PCR as a technique for malaria research. The study is anticipated to impact the therapeutic drug and vaccine studies for malaria. Researchers concluded that at-home dried blood spot collection cards for PCR are acceptable, robust, and feasible techniques.

On the other hand, it has been observed that dried blood spot collection cards are susceptible to cross-contamination or contamination by users, the environment, the equipment, and other collection cards during sample processing. The majority of these concerns can be mitigated by proper care and handling. Prolonged air drying of the conventional dried blood spot collection cards and contamination between samples during blood collection are some major causes of a high proportion of reactive samples.

Request a free sample copy or view report summary: Dried Blood Spot Collection Cards Market Report

Dried Blood Spot Collection Cards Market Report Highlights

• By application, the New Born Screening (NBS) segment accounted for the largest revenue in 2021. An increase in research activities to enhance newborn screening is a major factor expected to fuel market growth
• By card type, the Whatman 903 segment dominated the market in 2021 and is expected to register the fastest growth rate from 2022 to 2030. At present, the Whatman paper is widely utilized in the testing of viral infections and the monitoring of therapeutic drugs
• North America dominated the market in 2021. This can be attributed to high healthcare expenditure, the presence of well-established healthcare infrastructure, and the high adoption of advanced dried blood spot collection cards in the U.S.
• The Asia Pacific region is anticipated to witness lucrative growth over the forecast period as a result of an increasing number of leading players in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dried-blood-spot-collection-cards-market

Dried Blood Spot Collection Cards Market Segmentation

Grand View Research has segmented the global dried blood spot collection cards market based on application, card type, and region:

Dried Blood Spot Collection Cards Application Outlook (Revenue, USD Million, 2018 - 2030)

• New Born Screening (NBS)
• Infectious Disease Testing
• Therapeutic Drug Monitoring
• Forensics
• CRO/Research
• Other Applications

Dried Blood Spot Collection Cards Type Outlook (Revenue, USD Million, 2018 - 2030)

• Whatman 903
• Ahlstrom 226
• FTA
• Others

Dried Blood Spot Collection Cards Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Dried Blood Spot Collection Cards Market

• QIAGEN
• Perkinelmer
• Roche
• Shimadzu Corporation
• Ahlstrom-Munksjö
• Pall Corporation
• Eastern Business Forms, Inc.
• Archimed Life Science GmbH
• Centogene N.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Single-use Assemblies Market During 2022– 2030 to Gain Robust Traction: Grand View Research Inc.

 Single-use Assemblies Market Growth & Trends

The global single-use assemblies market size is expected to reach USD 39.96 billion by 2030, registering a CAGR of 18.57% during the forecast period, according to a new report by Grand View Research, Inc. Life science companies are eager to avoid the cost and time of cleaning needed with stainless steel. The augmented expansion of the international biotech industries has offered a growth environment, in which novel, disposable technologies are becoming more significant. As pharmaceutical companies, distributors, CDMOs, and manufacturers converge around the benefits of single-use assemblies, the industry will grow at a faster pace during the forecast period. From therapies for rare diseases to cancer research, the impact of single-use technology in accelerating cutting-edge research into these conditions is set to grow, thereby propelling industry growth.

In addition, the growing biologics market will further offer lucrative opportunities during the study period. Eradicating the risk of contamination is the major challenge faced by biopharmaceutical manufacturers, which currently involves high-level monitoring of critical manufacturing solutions. Single-use assemblies support manufacturers in overcoming this difficulty by eliminating or reducing the necessity for sterilization between the batches, thereby filtering the operational capability. SUTs are considered one of the important areas of growth among biomanufacturing companies, as several biopharmaceutical companies are venturing into disposable assembly offerings for the production of all sorts of biopharmaceuticals.

Moreover, SUTs are now being heavily adopted for the clinical manufacturing of biopharmaceuticals and have become more conventional within commercial manufacturing facilities. SUTs permit biologics manufacturers to reduce the facilities' footprint by almost 20% due to the need for utilities, which generate steam, water, and clean-in-place solutions. Furthermore, as per the research by BioProcess International, the engineers estimated that the capital expenditure for the single-use facility is 25-45% less than for a facility established on stainless-steel equipment. Similarly, they also estimated that single-use facilities need half the energy and water during operations and can be built in 18 months. Whereas the stainless-steel facility takes three years. Owing to such advantages, the adoption of single-use assemblies is increasing, thereby driving industry growth.

In recent years, CMOs have been integrating single-use assemblies into most or all their bioprocess. CMOs broadly use single-use assemblies for quicker processing and process changeover time. The quick turnaround time and flexibility between process runs and various client projects allowed by single-use assemblies can enhance the CMO efficiency, which, in turn, aids in the reduction of the overall costs. In addition, the growing number of CMO facilities are essentially fully single-use. CMOs adoption of single-use technology can save on campaign and facility costs, which helps reduce the operating costs and capital investments. Furthermore, single-use assemblies in CMOs decrease the complexity and reduces lead times in upstream processes.

They also enhance the quality of products by preventing cross-contamination in downstream processes, especially for processes handling potent or toxic materials, such as antibody-drug conjugates and viral vectors. Moreover, stringent regulatory requirements in the manufacturing systems also endorse the adoption of single-use assemblies in CMOs.COVID-19 has augmented an already rapidly rising demand for single-use assemblies as the SUTs allow for the speedy production and development of therapies and vaccines and improve accuracy and time. For instance, Aramus single-use bag assembly developed by Entegris, Inc. was used for the storage of COVID-19 vaccines as the vaccines need extremely low temperatures to preserve. With low leachable and extractable and an extensive operating-temperature variety, the patented single-use bags were ideal for cold chain storage and collection.

In addition, key manufacturers are also accelerating investment projects or increasing their capital expenditures. For instance, Pall Corp., invested USD 114 million to upsurge its single-use output. These investments comprise additional manufacturing capacity at 6 current manufacturing facilities in the United States and Europe. Moreover, MilliporeSigma, Thermo Fisher, and Cytiva have also augmented growth plans to support the industry’s backlog. For instance, in March 2021 Merck announced the addition of a single-use assembly production unit at its Life Science Center in Molsheim, France. The investment of USD 26.25 million will accelerate the European expansion plans of the company for single-use products critical to manufacturing vaccines and lifesaving therapies. On the other hand, regulatory concerns due to leachable and extractable might hamper the growth of disposable assemblies in the forecast period.

Leachable and extractable are set of undesired impurities in the product stream, these are compounds that can move into the product from manufacturing systems, packaging containers, or other product-contact systems. Extractable is extracted from the contact materials under extreme conditions, such as treatment with a harsh solvent or elevated temperature conditions. Leachable compounds, on the other hand, are those that are leached into the final product from contact materials during normal or real-time storage conditions. North America dominated the global industry in 2021 due to the growth in the biotechnology and pharmaceutical industries, advancement in SUT products, and increasing incidence of diseases, such as cancer coupled with increasing investments and funding in drug discovery research. Asia Pacific is expected to grow at a considerable CAGR over the forecast years owing to the strategic activities by key players coupled with funding by the government for biopharmaceutical R&D.

Request a free sample copy or view report summary: Single-use Assemblies Market Report

Single-use Assemblies Market Report Highlights

• The filtration assemblies segment led the industry in 2021. Increased regulatory prospects and the need to diminish the risk of contamination have promoted the use of filtration assemblies for bulk and final fill operations
• The bag assemblies segment is expected to grow at a lucrative CAGR over the forecast period. Advantages, such as no need for validation or cleaning, lower shipping cost due to less weight, and low maintenance cost & capital investment drive the segment growth
• The filtration application segment held a larger revenue share in 2021. Implementation of single-use assemblies for filtration is rapidly increasing owing to benefits as it is time- & cost-effective and ready to use, unlike the conventional filtration systems
• The customized solutions segment captured the highest revenue share in 2021. Several companies offer customized solutions to fast-track pharmaceutical manufacturing and drug development
• The pharmaceutical & biotechnological companies end-user segment led the global industry in 2021. The growth of the current manufacturing facilities for biopharmaceuticals drives the demand for single-use assemblies
• The CROs & CMOs segment is expected to grow at the fastest CAGR over the forecast period. In recent years, CMOs have been integrating single-use technology into most or all their bioprocess
• The quick turnaround time and flexibility between process runs and various client projects allowed by single-use equipment can enhance the CMO efficiency, which aids in the reduction of the overall costs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-single-use-assemblies-market

Single-use Assemblies Market Segmentation

Grand View Research has segmented the global single-use assemblies market based on product, application, solution, end-user, and region:

Single-use Assemblies Product Outlook (Revenue, USD Million, 2018 - 2030)

• Bag Assemblies
  • 2D bag assemblies
  • 3D bag assemblies
• Filtration Assemblies
• Bottle Assemblies
• Tubing Assemblies
• Other Products

Single-use Assemblies Application Outlook (Revenue, USD Million, 2018 - 2030)

• Filtration
• Cell Culture & Mixing
• Storage
• Sampling
• Fill-finish Applications
• Other Applications

Single-use Assemblies Solution Outlook (Revenue, USD Million, 2018 - 2030)

• Customized Solutions
• Standard Solutions

Single-use Assemblies End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes

Single-use Assemblies Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Single-use Assemblies Market

• Thermo Fisher Scientific
• Sartorius AG  
• Danaher Corp.
• Merck KGaA  
• Avantor
• Lonza
• Saint-Gobain
• Corning Inc.
• Entegris
• KUHNER AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aroma Chemicals Market to Observe Strong Development by 2030: Grand View Research Inc.

 Aroma Chemicals Market Growth & Trends

The global aroma chemicals market size is expected to reach USD 7.72 billion by 2030, as per the new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 4.1% from 2022 to 2030. The growth is majorly driven by natural aroma chemicals in developed economies of North America and Europe. The aromatherapy industry has grown tremendously owing to the high diversity in consumer preferences for natural aromatic products such as essential oils, fragrances, and others for the treatment of several diseases. Changing lifestyles and its consequences such as depression and stress have resulted in a growing demand for aromatherapy directly fueling the growth in demand for aroma chemicals.

The terpenes & terpenoids segment emerged as the largest chemical segment in 2021 owing to its increasing demand from the rubber as well as paints & coatings industry. Aroma chemicals are getting essential for the formulation of additives for health & personal care, food & beverage products, thus forming a stable market. Further, regarding the evolving consumer demands and overall industry scenario, the manufacturers are inclined towards formulating natural aroma chemicals offering flavors close to synthetic flavoring agents to gain a competitive edge in the industry.

The key industry players are mostly integrated across the value chain from manufacturing to distribution to maintain the quality of raw materials. Owing to this, the key players are gaining a competitive advantage regarding cost benefits with increased profit margins. New market entrants are looking for opportunities to enter the global aroma chemicals market; wherein new entrants attempting to establish themselves have to contend with top multinationals, such as Takasago International Corporation, Symrise, Robertet, MANE, Firmenich SA, and Givaudan.

Request a free sample copy or view report summary: Aroma Chemicals Market Report

Aroma Chemicals Market Report Highlights

• Natural source segment is estimated to witness a CAGR of 3.8% over the forecast period, due to a shift in trend for natural products, especially from the flavors industry
• Flavors is projected to be the fastest growing segment over the forecast period due to the growing consumption of flavors across several end-use applications such as beverages, convenience food, bakery food, and dairy
• The terpenes & terpenoids segment is anticipated to witness the fastest CAGR of 4.5% due to its natural availability as well as its anti-carcinogenic, antiseptic, and antimicrobial effects
• Asia Pacific constituted a major revenue share in 2021 and is also anticipated to continue its dominance over the forecast period, due to high domestic consumption in countries such as India and China
• MANE, Takasago International Corporation, and Robertet are among the prominent industry participants with a broad product portfolio and high segmental share. Key players holding less than 1% of the market share each are characterized as niche players which have limited regional operations or have low to medium aroma chemical product offerings

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aroma-chemicals-market

Aroma Chemicals Market Segmentation

Grand View Research has segmented the global aroma chemicals market based on source, chemical, application, and region:

Aroma Chemicals Source Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Natural
• Synthetic
• Natural-identical

Aroma Chemicals Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Benzenoids
• Musk chemicals
• Terpenes & Terpenoids
• Others (Ketones, Esters, Aldehydes)

Aroma Chemicals Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Flavors
  • Confectionery
  • Convenience Food
  • Bakery Food
  • Dairy Products
  • Beverages
  • Others
• Fragrances
  • Fine Fragrance
  • Cosmetics and Toiletries
  • Soaps and Detergents
  • Others

Aroma Chemicals Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players in Aroma Chemicals Market

• Privi Organics India Limited
• BASF SE
• Kao Corporation
• Takasgo International Corporation
• Givaudan
• Bell Flowers & Fragrances
• Symrise
• S H Kelkar and Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cardiac Catheters & Guidewires Market Forecasted to Grow at Steady Pace During 2022-2030: Grand View Research Inc.

 Cardiac Catheters & Guidewires Market Growth & Trends

The global cardiac catheters & guidewires market size is anticipated to reach USD 24.92 billion by 2030, registering a CAGR of 7.56% from 2022 to 2030, according to a new report by Grand View Research, Inc. The industry is expected to grow due to the increasing geriatric population, lack of substitutes in the market, rising incidence of diabetes across the globe, and technological advancements. Diabetic patients are more prone to develop certain health conditions, such as high cholesterol, high blood pressure, heart diseases, and stroke. In addition, long-term diabetes damages the blood vessels and nerves that directly control the heart muscles. This also increases the chances of developing Cardiovascular Diseases (CVDs).

Moreover, people suffering from diabetes also tend to develop heart disease and stroke at a very young age. Furthermore, diabetes triggers the risk of developing obesity, which, in turn, increases the predisposition to CVDs. The high incidence of diabetes is one of the major reasons for the increased prevalence of CVDs across the globe. For instance, according to the American Diabetes Association, around 37.3 million Americans, which was around 11.3% of the total population, were estimated to be suffering from diabetes. Moreover, as per the 10th edition of the International Diabetes Federation, 537 million people worldwide have diabetes, which is anticipated to reach 700 million by 2045. Furthermore, in recent years, the Caribbean, Middle East, Latin America regions, and some nations of the Pacific Islands marked the highest prevalence of diabetes in the world.

Moreover, technological advancements in cardiac catheters & guidewires devices can support clinicians in identifying patients with a high risk of disease, which is anticipated to spur the industry growth. For instance, in February 2022, Medtronic received FDA expanded approval for cryoablation cardiac catheters for pediatric patients for the treatment of a common heart rhythm disorder. Hence, such product launches provide growth opportunities. The COVID-19 pandemic had a negative impact on the industry due to a decrease in surgical procedure volumes. However, due to the ease in restrictions, countries have resumed elective procedures, suggesting that the industry will keep growing during the projected period.

Request a free sample copy or view the report summary: Cardiac Catheters & Guidewires Market Report

Cardiac Catheters & Guidewires Market Report Highlights

• The cardiac catheters segment led the industry in 2021 due to the introduction of technologically advanced products, rising number of coronary interventional procedures, and increasing incidence of diabetes
• The hospital end-use segment is expected to lead the industry during the forecast years due to the increasing prevalence of chronic diseases, rapidly growing geriatric population, and technological advancements in catheters
• Asia Pacific is expected to register the fastest CAGR over the forecast period. Growing awareness levels, increasing disposable income, and rising incidence of chronic conditions are the key factors boosting the region’s growth
• The industry is highly competitive due to the presence of many international companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cardiac-catheters-guidewires-market

Cardiac Catheters & Guidewires Market Segmentation

Grand View Research has segmented the global cardiac catheters & guidewires market based on product, end-use, and region:

Cardiac Catheters & Guidewires Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac Catheters
  • Electrophysiology catheters
  • PTCA balloons catheters
  • IVUS catheters
  • PTA balloons catheters
  • Guide extension catheter
  • Others
• Cardiac Guidewires

Cardiac Catheters & Guidewires End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Cardiac Catheters & Guidewires Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Cardiac Catheters & Guidewires Market

• Abbott
• Boston Scientific Corp.
• Getinge AB
• Biosense Webster, Inc (Part of Johnson & Johnson)
• Terumo Medical Corp.
• BIOTRONIK SE & Co. KG
• Medtronic
• CORDIS (A, Cardinal Health Company)
• QXMédical
• Teleflex Inc.
• Braun
• R., Bard, Inc (has joined BD)
• Cardinal Health
• Merit Medical Systems
• NIPRO
• BrosMed Medical Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Toxicity Testing Outsourcing Market Trends Analysis And Forecast Till 2030: Grand View Research Inc.

 Toxicity Testing Outsourcing Market Growth & Trends

The global toxicity testing outsourcing market size is expected to reach USD 6.78 billion by 2030, registering a CAGR of 9.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing attrition rate in preclinical studies is stimulating demand for the outsourcing of preclinical studies to the CROs, which offer end-to-end services including toxicology testing services. Also, rising growth and innovation in pharmaceutical and biopharmaceutical companies, augment in R&D, and increasing ethical concerns about animal use are driving the enlargement of the market.

COVID-19 has significantly impacted the market for toxicity testing outsourcing. During the crisis, vaccine, medical device, and biologic contract research and manufacturing service providers played a predominant role in meeting the needs of pharmaceutical companies, biotech companies, and other end users. These organizations have been actively working towards the development of healthcare products that can be used as a treatment for patients, suffering from COVID-19 with mild symptoms, since the end of 2019. And these products require toxicity testing at each stage to assess safety and effectiveness, thus contributing to market growth.

Companies in the pharmaceutical and biopharmaceutical industries operate in an environment that is becoming more complex to understand. Improvements in many therapeutic areas, as well as the emergence of new types of therapies such as genetically targeted therapies, biologics, stem cell therapies, and other treatment modalities, have resulted in more complex development and regulatory pathways. To develop a treatment that is secure and efficient, it is necessary to do toxicity testing at each stage, which is boosting the market's growth.

Request a free sample copy or view the report summary: Toxicity Testing Outsourcing Market Report

Toxicity Testing Outsourcing Market Report Highlights

• The method segment is segmented into in vitro and in vivo. In vitro accounted for the largest market share of 57.7% in 2021
• The academic and research institutes segment is anticipated to grow at the fastest CAGR of 9.6% during the forecast period. This is due to the rising research on novel drugs intended for various therapeutic areas
• Asia Pacific accounted for the fastest CAGR of 11.3% during the forecast period, owing to the cost efficiency offered by CROs and CDMOs in countries such as India and China
• In February 2022, Charles River Laboratories International, Inc. announced an expansion of its manufacturing capacity in Brunt wood SciTech’s Alderley Park in Europe

Access Press Release@ https://www.grandviewresearch.com/press-release/global-toxicity-testing-outsourcing-market

Toxicity Testing Outsourcing Market Segmentation

Grand View Research has segmented the global toxicity testing outsourcing market based on the method, GLP type, end-use, and region:

Toxicity Testing Outsourcing Method Outlook (Revenue, USD Million, 2018 - 2030) 

• In vitro
• In vivo

Toxicity Testing Outsourcing GLP Type Outlook (Revenue, USD Million, 2018 - 2030)         

• GLP
• Non GLP

Toxicity Testing Outsourcing End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Others

Toxicity Testing Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Toxicity Testing Outsourcing Market

• Euro fins Scientific
• SGS SA
• Charles River Laboratories
• Thermo Fisher Scientific, Inc.
• Intertek Group plc,
• Catalent, Inc.
• ICON plc.
• Med pace
• Labcorp Drug Development
• Wuxi AppTec

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.